These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29730194)

  • 21. Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry).
    AlFaleh H; Elasfar AA; Ullah A; AlHabib KF; Hersi A; Mimish L; Almasood A; Al Ghamdi S; Ghabashi A; Malik A; Hussein GA; Al-Murayeh M; Abuosa A; Al Habeeb W; Kashour TS
    BMC Cardiovasc Disord; 2016 May; 16():98. PubMed ID: 27206336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants and Prognostic Impact of Heart Failure and Left Ventricular Ejection Fraction in Acute Coronary Syndrome Settings.
    Agra Bermejo R; Cordero A; García-Acuña JM; Gómez Otero I; Varela Román A; Martínez Á; Álvarez Rodríguez L; Abou-Jokh C; Rodríguez-Mañero M; Cid Álvarez B; López-Palop R; Carrillo P; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):820-828. PubMed ID: 29249471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction.
    Cypen J; Ahmad T; Testani JM; DeVore AD
    Curr Heart Fail Rep; 2017 Oct; 14(5):434-443. PubMed ID: 28803400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation.
    Baba M; Yoshida K; Ieda M
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of acute heart failure and relevance of biomarkers in elderly patients].
    Ruiz Ortega RA; Manzano L; Montero-Pérez-Barquero M
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():20-5. PubMed ID: 24930079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of glycemia in acute heart failure patients.
    Seferović JP; Milinković I; Tešić M; Ristić A; Lalić N; Simeunović D; Zivković I; Di Somma S; Seferovic PM
    Clin Chem Lab Med; 2014 Oct; 52(10):1437-46. PubMed ID: 24988247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of prognostic value of echographic [corrected] risk score with the Thrombolysis in Myocardial Infarction (TIMI) and Global Registry in Acute Coronary Events (GRACE) risk scores in acute coronary syndrome.
    Bedetti G; Gargani L; Sicari R; Gianfaldoni ML; Molinaro S; Picano E
    Am J Cardiol; 2010 Dec; 106(12):1709-16. PubMed ID: 21126614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function.
    Palazzuoli A; Maisel A; Caputo M; Fineschi M; Quatrini I; Calabrò A; Campagna MS; Franci B; Grothgar S; Pierli C; Nuti R
    Regul Pept; 2011 Feb; 167(1):129-33. PubMed ID: 21237213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial).
    Harkness JR; Morrow DA; Braunwald E; Ren F; Lopez-Sendon J; Bode C; Budaj A; Scirica BM
    Am J Cardiol; 2011 Nov; 108(10):1373-81. PubMed ID: 21890090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biomarkers in risk stratification of acute coronary syndrome without ST elevation: is there anything after troponin?].
    Tello-Montoliu A; Marín F
    Med Clin (Barc); 2009 Oct; 133(15):586-8. PubMed ID: 19804891
    [No Abstract]   [Full Text] [Related]  

  • 33. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical value of determination of natriuretic peptides in acute coronary syndrome].
    Shreĭder EV; Shakhnovich RM; Ruda MIa
    Ter Arkh; 2010; 82(9):63-8. PubMed ID: 21086624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.
    Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED
    Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
    Morbach C; Marx A; Kaspar M; Güder G; Brenner S; Feldmann C; Störk S; Vollert JO; Ertl G; Angermann CE;
    Eur J Heart Fail; 2017 Sep; 19(9):1166-1175. PubMed ID: 28516504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Nutritional Index and the Risk of Mortality in Patients With Acute Heart Failure.
    Cheng YL; Sung SH; Cheng HM; Hsu PF; Guo CY; Yu WC; Chen CH
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
    Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review.
    Garg A; Virmani D; Agrawal S; Agarwal C; Sharma A; Stefanini G; Kostis JB
    Cardiology; 2017; 136(3):192-203. PubMed ID: 27784010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.